IL133055A0 - A polypeptide containing an antigenic portion of m tuberculosis antigen a variant thereof and a method for detecting m tuberculosis infection - Google Patents

A polypeptide containing an antigenic portion of m tuberculosis antigen a variant thereof and a method for detecting m tuberculosis infection

Info

Publication number
IL133055A0
IL133055A0 IL13305598A IL13305598A IL133055A0 IL 133055 A0 IL133055 A0 IL 133055A0 IL 13305598 A IL13305598 A IL 13305598A IL 13305598 A IL13305598 A IL 13305598A IL 133055 A0 IL133055 A0 IL 133055A0
Authority
IL
Israel
Prior art keywords
tuberculosis
variant
detecting
polypeptide containing
antigenic portion
Prior art date
Application number
IL13305598A
Other languages
English (en)
Original Assignee
Corixa Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Corixa Corp filed Critical Corixa Corp
Publication of IL133055A0 publication Critical patent/IL133055A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/35—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • Plant Pathology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL13305598A 1997-05-20 1998-05-20 A polypeptide containing an antigenic portion of m tuberculosis antigen a variant thereof and a method for detecting m tuberculosis infection IL133055A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US85899897A 1997-05-20 1997-05-20
US09/073,009 US6555653B2 (en) 1997-05-20 1998-05-05 Compounds for diagnosis of tuberculosis and methods for their use
PCT/US1998/010514 WO1998053076A2 (fr) 1997-05-20 1998-05-20 Composes permettant de diagnostiquer la tuberculose et leurs procedes d'utilisation

Publications (1)

Publication Number Publication Date
IL133055A0 true IL133055A0 (en) 2001-03-19

Family

ID=26754013

Family Applications (1)

Application Number Title Priority Date Filing Date
IL13305598A IL133055A0 (en) 1997-05-20 1998-05-20 A polypeptide containing an antigenic portion of m tuberculosis antigen a variant thereof and a method for detecting m tuberculosis infection

Country Status (10)

Country Link
US (1) US6555653B2 (fr)
KR (1) KR20010012813A (fr)
AU (1) AU7591698A (fr)
BR (1) BR9809443A (fr)
CA (1) CA2290754A1 (fr)
IL (1) IL133055A0 (fr)
NO (1) NO995690L (fr)
PL (1) PL337333A1 (fr)
TR (1) TR200000113T2 (fr)
WO (1) WO1998053076A2 (fr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6991797B2 (en) 1993-07-02 2006-01-31 Statens Serum Institut M. tuberculosis antigens
US6458366B1 (en) 1995-09-01 2002-10-01 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
US6592877B1 (en) 1995-09-01 2003-07-15 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6290969B1 (en) * 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
US6544522B1 (en) * 1998-12-30 2003-04-08 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses
US6982085B2 (en) 1997-04-02 2006-01-03 Statens Serum Institut TB diagnostic based on antigens from M. tuberculosis
US7037510B2 (en) 1997-04-18 2006-05-02 Statens Serum Institut Hybrids of M. tuberculosis antigens
CA2319380A1 (fr) * 1997-11-10 1999-05-20 Statens Serum Institut Fragments d'acides nucleiques et fragments polypeptidiques derives de m. tuberculosis
US8143386B2 (en) * 1999-04-07 2012-03-27 Corixa Corporation Fusion proteins of mycobacterium tuberculosis antigens and their uses
JP5075969B2 (ja) * 1999-07-13 2012-11-21 スタテンズ セーラム インスティテュート マイコバクテリウム・ツベルクローシスｅｓａｔ−６遺伝子ファミリーベースの結核ワクチン及び診断法
CA2378763A1 (fr) * 1999-07-13 2001-01-18 Statens Serum Institut Vaccins et produits de diagnostic pour la tuberculose derives de la famille genique mycobacterium tuberculosis esat-6
WO2001009165A2 (fr) * 1999-07-29 2001-02-08 The Johns Hopkins University ACTIVATION DE PROMEDICAMENTS PEPTIDIQUES PAR hK2
CA2386841A1 (fr) 1999-10-07 2001-04-12 Corixa Corporation Proteines hybrides de mycobacterium tuberculosis
US6316205B1 (en) 2000-01-28 2001-11-13 Genelabs Diagnostics Pte Ltd. Assay devices and methods of analyte detection
WO2001062893A2 (fr) * 2000-02-25 2001-08-30 Corixa Corporation Composes et methodes de diagnostic et d'immunotherapie de la tuberculose
EP1278769A2 (fr) * 2000-04-19 2003-01-29 Statens Serum Institut Antigenes de la tuberculose et procedes de leur utilisation
CA2413959C (fr) * 2000-06-20 2015-07-07 Corixa Corporation Proteines de fusion du mycobacterium tuberculosis
JP2005504523A (ja) 2001-06-22 2005-02-17 ヘルス プロテクション エージェンシー 低酸素圧下で発現するマイコバクテリア抗原
AU2002314358C1 (en) 2001-07-04 2009-03-26 The Secretary Of State For Health Mycobacterial antigens expressed during latency
US20030199012A1 (en) * 2002-02-01 2003-10-23 Ho John L. Compositions and methods for treatment of infectious and inflammatory diseases
US20050267025A1 (en) * 2002-02-01 2005-12-01 Ho John L Compositions and methods for treatment of infectious and inflammatory diseases
US7026465B2 (en) 2002-02-15 2006-04-11 Corixa Corporation Fusion proteins of Mycobacterium tuberculosis
US8475735B2 (en) * 2004-11-01 2013-07-02 Uma Mahesh Babu Disposable immunodiagnostic test system
NZ555907A (en) * 2004-11-16 2009-12-24 Aeras Global Tb Vaccine Found Multivalent vaccines comprising recombinant viral vectors
CA2606962A1 (fr) * 2005-04-29 2006-11-09 Fusion Antibodies Limited Dosages et leur utilisation
ATE530569T1 (de) 2005-07-01 2011-11-15 Forsyth Dental In Ry For Children Fa Assays zum nachweis von tuberkulose- antigenen, und impfstoffe
WO2007041539A1 (fr) * 2005-09-30 2007-04-12 Transcutaneous Technologies, Inc. Appareil d'iontophorese et methode de diagnostic de la tuberculose
EP2397856B1 (fr) 2006-03-14 2013-11-13 Oregon Health and Science University Procédés pour détecter une infection de tuberculose à mycobactérie
WO2007136781A2 (fr) * 2006-05-18 2007-11-29 Ericson Daniel G Procédé de détection rapide de mycobacterium tuberculosis et de résistance à un médicament antimicrobien
EP2468300B1 (fr) 2006-09-26 2017-12-20 Infectious Disease Research Institute Composition de vaccin contenant un adjuvant synthétique
US20090181078A1 (en) 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
CN102481312B (zh) 2009-06-05 2015-07-15 传染性疾病研究院 合成的吡喃葡萄糖脂佐剂
DK2528621T3 (da) 2010-01-27 2017-01-02 Glaxosmithkline Biologicals Sa Modificerede tuberkuloseantigener
GB201012072D0 (en) 2010-07-19 2010-09-01 Sec Dep For Environment Food A Diagnostic reagents
EA027236B1 (ru) 2011-04-08 2017-07-31 Иммьюн Дизайн Корп. Иммуногенные композиции и способы применения таких композиций для индукции гуморального и клеточного иммунного ответа
US10703784B2 (en) * 2011-09-30 2020-07-07 La Jolla Institute For Allergy And Immunology Antigens and epitopes derived from Mycobacterium tuberculosis
ES2729967T3 (es) 2012-02-07 2019-11-07 Infectious Disease Res Inst Formulaciones de adyuvante mejoradas que comprenden agonistas de TLR4 y métodos para usar las mismas
EP2812704A4 (fr) * 2012-02-07 2016-03-23 Intuitive Biosciences Inc Peptides spécifiques du bacille de koch pour la détection d'une infection ou d'une immunisation chez des primates non humains
EP3388835B1 (fr) 2012-05-16 2020-04-01 Immune Design Corp. Vaccins contre le hsv-2
CN105209047B (zh) 2013-04-18 2020-08-18 免疫设计股份有限公司 用于癌症治疗的gla单一疗法
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
US11801223B2 (en) 2013-12-31 2023-10-31 Access To Advanced Health Institute Single vial vaccine formulations
RU2613320C2 (ru) * 2015-06-29 2017-03-15 Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт фтизиопульмонологии" Министерства здравоохранения Российской Федерации (ФГБУ "УНИИФ" Минздрава России) Способ прогнозирования течения туберкулеза
MX2018014399A (es) 2016-06-01 2019-06-06 Infectious Disease Res Inst Particulas de nanoalumbre que contienen un agente de dimensionamiento.
CA3141577A1 (fr) 2019-05-25 2020-12-03 Infectious Disease Research Institute Composition et procede de sechage par atomisation d'une emulsion de vaccin et d'adjuvant

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4689397A (en) 1985-08-12 1987-08-25 Scripps Clinic And Research Foundation Synthetic polypeptides for detecting mycobacterial infections
US4879213A (en) 1986-12-05 1989-11-07 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
US4952395A (en) 1987-02-26 1990-08-28 Scripps Clinic And Research Foundation Mycobacterial recombinants and peptides
US4976958A (en) 1987-02-26 1990-12-11 Scripps Clinic And Research Foundation Mycobacterial recombinants and peptides
US5330754A (en) 1992-06-29 1994-07-19 Archana Kapoor Membrane-associated immunogens of mycobacteria
US6290969B1 (en) * 1995-09-01 2001-09-18 Corixa Corporation Compounds and methods for immunotherapy and diagnosis of tuberculosis
TR200806258T2 (tr) 1995-09-01 2008-10-21 Corixa Corporation Tüberkülozun teşhisi ve immünoterapi yolu ile önlenmesine mahsus yöntemler ve bileşikler
US6338852B1 (en) * 1995-09-01 2002-01-15 Corixa Corporation Compounds and methods for diagnosis of tuberculosis
WO1997009429A2 (fr) 1995-09-01 1997-03-13 Corixa Corporation Composes et methodes de diagnostic de la tuberculose
KR19990087802A (ko) * 1996-03-15 1999-12-27 길리스 스티브 전립선암의 면역치료 및 면역진단을 위한 화합물 및 방법
US5985287A (en) * 1996-08-29 1999-11-16 Genesis Research And Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6284255B1 (en) * 1996-08-29 2001-09-04 Genesis Research & Development Corporation Limited Compounds and methods for treatment and diagnosis of mycobacterial infections
US6350456B1 (en) * 1997-03-13 2002-02-26 Corixa Corporation Compositions and methods for the prevention and treatment of M. tuberculosis infection

Also Published As

Publication number Publication date
WO1998053076A2 (fr) 1998-11-26
WO1998053076A3 (fr) 1999-04-01
NO995690L (no) 2000-01-18
US20010012888A1 (en) 2001-08-09
PL337333A1 (en) 2000-08-14
US6555653B2 (en) 2003-04-29
CA2290754A1 (fr) 1998-11-26
BR9809443A (pt) 2000-06-13
AU7591698A (en) 1998-12-11
KR20010012813A (ko) 2001-02-26
NO995690D0 (no) 1999-11-19
TR200000113T2 (tr) 2000-05-22

Similar Documents

Publication Publication Date Title
IL133055A0 (en) A polypeptide containing an antigenic portion of m tuberculosis antigen a variant thereof and a method for detecting m tuberculosis infection
AU2637395A (en) Method and apparatus useful for detecting bloodgroup antigens and antibodies
EP0964640A4 (fr) Procede et appareil de detection d'une substance a reponse magnetique
IL125675A0 (en) A method and system for radio-location determination
PL333237A1 (en) Method of and device for air modification
EP1042691A4 (fr) Procede et appareil pour determiner l'emplacement des caracteristiques d'un pipeline
AU6826798A (en) Method and device for detecting specific states of movement of a user
IL117021A (en) Assay device and a method for detecting the presence of an analyte
GB2283819B (en) Method and device for operating an ultrasonic sensor
IL121936A0 (en) Polypeptides containing a tuberculosis antigen compositions containing the same and methods for diagnosis of tuberculosis utilizing the same
AU3623595A (en) Method and device for gas sensing
AU4650797A (en) Method and apparatus useful for detecting bloodgroup antigens and antibodies
PL319374A1 (en) Region v proteins of t cell antigen receptor and method of obtaining them
AU6912698A (en) Device and method for determining the position of a point
AU745401C (en) Method and device for strapping individual objects or stacks of objects
EE9800449A (et) Meetod ja seade kasutajamenüü informatsiooni käitlemiseks kasutaja seadmes
GB2294328B (en) Semiconductor acceleration sensor and testing method thereof
HUP0000320A3 (en) Peptide and a method of obtaining it
BR9607251A (pt) Método de carregamento magnético de um material de sinterização
IL128125A0 (en) Method and device for sensing a clearance
AU2869900A (en) Method and apparatus for detecting a magnetically responsive substance
AU7680998A (en) Method and device for contactless measuring of movement
GB2321964B (en) Method of and apparatus for detecting a surface condition of a wafer
AU2696495A (en) Method for determining hiv-1 antigen and antibody
AU3752595A (en) Method and device for determination of proteins employing antigen/antibody reactions